Salient Bio, a UK diagnostic firm, has launched the fastest robotics-driven Covid-19 mass testing platform, reports Pharma Phorum. The company claims that the platform can provide results with a 99% accuracy. There are different mass testing approaches, one being the breath test which has prompted the trial of the Microtox device. The UK is also conducting a mass trial programme at Liverpool, which has a surge in virus infections.
BASE10 Genetics and DNA Link have announced a collaboration to evaluate the use and efficacy of DNA Link’s AccuFind COVID-19 IgG antibody test in a point-of-care healthcare setting. Although Covid-19 cases and mortality rates have witnessed a recent surge in the US, many individuals have also recovered from the infection.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Biolidics Limited has entered into a deal with the Chinese biotech company, JOYSBIO, to develop and/or distribute the latter’s certified SARS-CoV-2 Antigen Rapid Test Kit. Under the terms of the agreement, Biolidics will distribute the kits worldwide for a period of one year from the date of the agreement.
Alberta Health Minister Tyler Shandro, the health minister has announced that the province is launching rapid Covid-19 tests in December to fast-track testing of all individuals showing Covid-19 symptoms and to track down everyone infected within the territory. Shandro stated that almost 100,000 PanBio and Abbott IDNow rapid-test kits were available for distribution and will be sent as a test pilot across the province to curb the spread of the disease.
